Table 1

Participant demographics and characteristics

ID	Age	Gender	PNES duration (years)	No. of attacks in previous month	Type of symptoms^*	Medication	MRI remarks
1	39	F	1	3	Unresponsiveness	–
2	40	F	13	0	Major motor manifestations	–
3	50	F	6	5	Major motor manifestations	–
5	25	F	3	1	Major motor manifestations	–
6	52	M	13	1	Major motor manifestations	Amitriptyline, rosuvastatin, oxazepam	Cerebral atrophy
8	28	M	14	0	Major motor manifestations	Diazepam
9	37	M	3	8	Unresponsiveness	2008–2010 Valproic acid, topiramate Sumatriptan and naratriptan
10	36	F	27	2	Unresponsiveness	–
11	20	M	1	2	Unresponsiveness	–
12	28	F	2	0	Major motor manifestations & unresponsiveness	–
13	18	M	1	0	Major motor manifestations	October 2009–April 2010 Valproic acid	Asymmetrical ventricular system
C1	55	M				–	Diffuse white matter abnormalities
C2	52	F				–
C3	29	F				–
C4	27	F				–	Small aspecific white matter abnormality
C5	24	M				–
C6	39	F				–	Small lacunar lesion and slight atrophy
C7	37	F				–
C8	37	F				–
C10	32	M				–	Somewhat plump ventricular system
C11	25	F				–
C12	23	F				–	Small arachnoidal cyst right temporal pole
C13	23	M				–